Literature DB >> 9497342

Regulatory activities of the 5'- and 3'-untranslated regions and promoter of the human aggrecan gene.

W B Valhmu1, G D Palmer, J Dobson, S G Fischer, A Ratcliffe.   

Abstract

Identification and characterization of the regulatory elements of the human aggrecan gene are necessary first steps in addressing the molecular mechanisms through which the gene is regulated. Using luciferase reporter constructs driven by the human aggrecan promoter or the cytomegalovirus promoter, the 5'- and 3'-untranslated regions of the human aggrecan gene were found to regulate gene expression transcriptionally in a promoter- and/or cell type-specific manner. Independent of cell type, the 5'-untranslated region was inhibitory with respect to the cytomegalovirus promoter, but it was stimulatory to the human aggrecan promoter. The 5'-untranslated region inhibited the cytomegalovirus promoter by approximately 60% in both chondrocytes and NIH 3T3 cells, but it stimulated the activity of the human aggrecan promoter about 8-fold in chondrocytes and 40-fold in NIH 3T3 cells. In contrast, the 3'-untranslated region inhibited the activities of the human aggrecan promoter by 40-70% in both cell types, but it stimulated the cytomegalovirus promoter activities by 50-60% in NIH 3T3 cells and inhibited its activity by 70% in chondrocytes. The differential effects of the untranslated regions on the two types of promoters may be a reflection of differences in regulation of TATA-less promoters, such as the human aggrecan promoter, and TATA-containing promoters, such as the cytomegalovirus promoter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9497342     DOI: 10.1074/jbc.273.11.6196

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression.

Authors:  Raquel Sitcheran; Pankaj Gupta; Paul B Fisher; Albert S Baldwin
Journal:  EMBO J       Date:  2005-01-20       Impact factor: 11.598

2.  Cartilage-Specific Cre Recombinase Transgenes/Alleles in the Mouse.

Authors:  Ioannis Kanakis; Mohammad Alhashmi; Ke Liu; Craig Keenan; Lorenzo Ramos Mucci; Blandine Poulet; George Bou-Gharios
Journal:  Methods Mol Biol       Date:  2021

3.  A wide range of protective and predisposing variants in aggrecan influence the susceptibility for otosclerosis.

Authors:  Allan Thomas Højland; Lisse J M Tavernier; Guy Van Camp; Erik Fransen; Isabelle Schrauwen; Manou Sommen; Vedat Topsakal; Isabelle Schatteman; Ingeborg Dhooge; Alex Huber; Diego Zanetti; Henricus P M Kunst; Alexander Hoischen; Michael B Petersen
Journal:  Hum Genet       Date:  2021-08-19       Impact factor: 4.132

4.  Regulation of xylosyltransferase I gene expression by interleukin 1β in human primary chondrocyte cells: mechanism and impact on proteoglycan synthesis.

Authors:  Mostafa Khair; Mustapha Bourhim; Lydia Barré; Dong Li; Patrick Netter; Jacques Magdalou; Sylvie Fournel-Gigleux; Mohamed Ouzzine
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

Review 5.  Concepts in gene therapy for cartilage repair.

Authors:  Andre F Steinert; Ulrich Nöth; Rocky S Tuan
Journal:  Injury       Date:  2008-04       Impact factor: 2.586

6.  L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer.

Authors:  Yu Han; Véronique Lefebvre
Journal:  Mol Cell Biol       Date:  2008-06-16       Impact factor: 4.272

7.  Effects of sesamin on chondroitin sulfate proteoglycan synthesis induced by interleukin-1beta in human chondrocytes.

Authors:  Warunee Srisuthtayanont; Dumnoensun Pruksakorn; Prachya Kongtawelert; Peraphan Pothacharoen
Journal:  BMC Complement Altern Med       Date:  2017-05-31       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.